D-0338-2018 Class III Terminated
FDA drug recall D-0338-2018 was initiated by Mckesson Packaging Services on Jan 29, 2018 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification for assay (stability testing) The recall status is terminated (terminated Nov 24, 2020). Affected quantity: 24120 cups.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 14, 2018
- Initiation Date
- Jan 29, 2018
- Termination Date
- Nov 24, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24120 cups
Product description
Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
Reason for recall
Subpotent Drug: Out of specification for assay (stability testing)
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: 0114588, Exp 10/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0338-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026